Hypothesis

Delivering intermittent high‑intensity (>6,000 lux) 460 nm blue light in 12‑minute bouts with a 10‑Hz flash pattern within 30 min of waking will increase the proportion of slow‑wave sleep (SWS) and shorten REM latency compared with continuous equivalent intensity light.

Mechanistic Rationale

• Melanopsin‑expressing retinal ganglion cells respond preferentially to short‑wavelength light and exhibit heightened sensitivity to transient stimuli; flashing light can produce larger postsynaptic potentials than steady illumination [4].
• This transient drive augments glutamatergic signaling to the suprachiasmatic nucleus (SCN), strengthening the phase‑advancing signal and amplifying downstream autonomic output that raises overnight vagal tone, as indexed by higher HRV [5].
• It's well‑known that elevated vagal activity promotes thalamic reticular nucleus synchronization, fostering spindle‑slow wave complexes that are electrophysiological hallmarks of deep sleep generation.
• Enhanced SWS facilitates glymphatic clearance, which should lower cortical amyloid‑β burden and improve the Aβ42/40 ratio observed with better subjective sleep quality [6]
• Because intermittent light matches or exceeds continuous exposure for circadian entrainment [4], the protocol avoids saturation of melanopsin pathways while delivering a stronger phasic cue.

Testable Predictions

1. In a within‑subject crossover design, participants receiving the flashing blue‑light condition will show a ≥10 % relative increase in SWS percentage (measured by polysomnography or validated wearable EEG) compared with a continuous‑light control.
2. REM latency will be reduced by at least 5 min under the flashing condition.
3. Night‑to‑night HRV (RMSSD) will be elevated by ≥5 % during the first half of the night following flashing light exposure.
4. Changes in SWS will mediate the relationship between light condition and next‑day PSQI improvement, with mediation accounting for ≥30 % of the total effect.

Falsifiability

If the flashing protocol fails to produce a statistically significant increase in SWS or a decrease in REM latency relative to continuous light, or if HRV does not rise as predicted, the hypothesis is refuted. Additionally, blocking melanopsin signaling pharmacologically (e.g., with intravitreal antagonists in an animal model) should abolish the SWS enhancement, providing a mechanistic falsification.

Practical Implementation

• Use a programmable LED panel delivering 460 nm light at 6,500 lux.
• Flash at 10 Hz with a 50 % duty cycle for 12 minutes, starting within 10 minutes of wake time.
• Control condition: same total photon flux delivered as continuous light for 12 minutes.
• Record sleep with laboratory polysomnography or a validated forehead EEG wearable (e.g., Dreem, Philips SleepHead) for three consecutive nights per condition.
• Collect HRV via chest strap or high‑fidelity PPG, compute RMSSD for the first 90 minutes of sleep.

By linking phasic melanopsin activation to autonomic and cortical dynamics, this hypothesis bridges the gap between optimized morning light and quantitative sleep‑architecture improvements, offering a concrete, falsifiable route to refine circadian‑based interventions.